Related Experiment Video
Updated: May 19, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
The Impact of Metformin on Vitamin B12 Levels in Children and Adolescents: A Systematic Review and Single-Arm
Einas Abdullah Tahir1, Muhtadi G Ahmed2, Motasam Belah Al Swayah3
1Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Introduction:
The use of metformin among children and adolescents has risen in the past decade; however, its effect on vitamin B12 has been unclear. To address this gap, we conducted this first systematic review and single-arm meta-analysis.
Objective:
To investigate the effect of metformin on vitamin B12 levels.
Methods:
PubMed, Scopus and Web of Science were systematically searched until April 2025. The primary outcomes were the effect of metformin on vitamin B12 levels after 6 and 12 months of duration, and vitamin B12 deficiency after at least 12 months of usage. We conducted the risk-of-bias assessment using the NOS and Cochrane ROB2 tool. The mean difference (MD) and standard error (SE) were calculated and used for analysis. We assessed the heterogeneity of the studies using the chi-squared test and measured it with the I2 statistic. A fixed effects model was applied to calculate the pooled MD in the absence of significant heterogeneity. The registration number in PROSPERO 2025 is CRD420251045023.
Results:
A total of five articles were included in this systematic review and meta-analysis. The pooled rate of vitamin B12 deficiency in RCT studies after at least 12 months of use was 1.4% [95% CI: -0.012, 0.040] with mild heterogeneity (I2 = 30.87%, p = 0.235). While in observational studies the pooled rate was 18.7% [95% CI: -0.212, 0.586] with substantial heterogeneity (I2 = 87.93%, p = 0.004). Vitamin B12 levels decreased after 6 and 12 months of using metformin; however, it was neither statistically nor clinically significant (p > 0.05).
Conclusion:
More trials with larger sample sizes and longer durations of follow-up are needed to better understand the risk of vitamin B12 deficiency among the paediatric population.
Trial Registration:
PROSPERO (CRD420251045023).
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Oral Hypoglycemic Agents: Biguanides and Glitazones
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Dosing: Infants and Children
